naltrexone has been researched along with Drug Abuse, Intravenous in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.03) | 18.7374 |
1990's | 4 (12.12) | 18.2507 |
2000's | 11 (33.33) | 29.6817 |
2010's | 16 (48.48) | 24.3611 |
2020's | 1 (3.03) | 2.80 |
Authors | Studies |
---|---|
Robinson, CA; Wilson, JD | 1 |
Berry, MS; Bigelow, GE; Fingerhood, M; Holtyn, AF; Jarvis, BP; Silverman, K; Subramaniam, S; Umbricht, A | 1 |
Garg, A; Kumar, P; Prakash, O; Sinha, P | 1 |
Ahamad, K; Johnson, C; Kerr, T; Korthuis, TP; Milloy, MJ; Nguyen, P; Uhlmann, S; Wood, E | 1 |
Ang, A; Cousins, SJ; Crèvecoeur-MacPhail, D; Darfler, K; Radfar, SR; Rawson, RA | 1 |
Boney, TY; Bonnie, RJ; Chen, DT; Cornish, JW; Fishman, M; Friedmann, PD; Gordon, M; Gourevitch, MN; Hoskinson, RA; Kinlock, TW; Lee, JD; McDonald, R; Murphy, SM; Nunes, EV; O'Brien, CP; Rotrosen, J; Wilson, D | 1 |
Backonja, M; Bass, A; Malhotra, BK; Matschke, K; Setnik, B; Sommerville, KW; Webster, LR; Wolfram, G | 1 |
Blokhina, E; Chawarski, M; Desrosiers, A; Krupitsky, E; Schottenfeld, R; Zvartau, E | 1 |
Franck, J; Häggkvist, J; Lindholm, S | 1 |
Achat-Mendes, C; Platt, DM; Rowlett, JK; Spealman, RD; Valdez, GR | 1 |
Reece, AS | 1 |
Holt, E | 1 |
Curran, E; Fishman, MJ; Garrett, S; Subramaniam, G; Winstanley, EL | 1 |
Metzger, DS; Zhang, Y | 1 |
Krupitsky, E; O'Brien, CP; Woody, GE; Zvartau, E | 1 |
Jones, HE; Kirtadze, I; O'Grady, KE; Otiashvili, D | 2 |
Busch, EL; Elman, I; Langleben, DD; O'Brien, CP | 1 |
Aklin, WM; Bigelow, GE; Fingerhood, M; Lejuez, CW; Severtson, SG; Silverman, K; Umbricht, A | 1 |
Aklin, WM; Bigelow, GE; Defulio, A; Donlin, WD; Dunn, KE; Everly, JJ; Fingerhood, M; Leoutsakos, JM; Nuzzo, PA; Silverman, K; Umbricht, A | 1 |
Ahmadi, J; Ahmadi, K; Ohaeri, J | 1 |
Koutsogiannis, Z; Kronborg, I; Lubman, D | 1 |
Gerrits, MA; Kuzmin, AV; van Ree, JM | 1 |
Cubells, JF; Tang, YL; Zhao, C; Zhao, D | 1 |
Bespalov, AY; Burakov, AM; Didenko, TY; Egorova, VY; Grinenko, AY; Ivanova, EB; Krupitsky, EM; Masalov, DV; Neznanov, NG; O'Brien, CP; Romanova, TN; Tsoy, MV; Verbitskaya, EV; Woody, GE; Zvartau, EE | 1 |
Dore, GJ | 1 |
Bull, J; Chua, F; Galhenage, S; Hulse, G; Jeffrey, GP; MacQuillan, G; O'Neil, G; Young, E | 1 |
Greenwald, MK | 1 |
Jamaludin, A; Mansor, SM; Mohamed, M; Navaratnam, V; Raman, N | 1 |
Gutiérrez Mora, E; Lozano Polo, JL; Martínez Pérez, V; Santamaría Gutiérrez, J; Vada Sánchez, J; Vallejo Correas, JA | 1 |
Byrne, A | 1 |
Byck, R; Compton, M; Fleming, J; Gawin, FH; Jatlow, P; Kosten, T; Kosten, TA; Silverman, DG | 1 |
Schuster, CR; Snyder, M | 1 |
2 review(s) available for naltrexone and Drug Abuse, Intravenous
Article | Year |
---|---|
Drug treatment as HIV prevention: expanding treatment options.
Topics: Alcoholism; Buprenorphine; Clinical Protocols; Drug Users; Health Promotion; HIV Infections; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Risk Reduction Behavior; Risk-Taking; Substance Abuse, Intravenous; Substance-Related Disorders | 2010 |
Opiate addiction in China: current situation and treatments.
Topics: Buprenorphine; China; Clonidine; Drugs, Chinese Herbal; HIV Infections; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Abuse, Intravenous; Substance Withdrawal Syndrome; Sympatholytics | 2006 |
15 trial(s) available for naltrexone and Drug Abuse, Intravenous
Article | Year |
---|---|
Predictors of induction onto extended-release naltrexone among unemployed heroin-dependent adults.
Topics: Adult; Delayed-Action Preparations; Female; Heroin; Humans; Injections, Intramuscular; Male; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Substance Abuse Detection; Substance Abuse, Intravenous; Unemployment | 2018 |
Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.
Topics: Adult; Community Health Services; Counseling; Criminals; Delayed-Action Preparations; Drug Overdose; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Secondary Prevention; Substance Abuse, Intravenous | 2016 |
Intravenous abuse potential study of oxycodone alone or in combination with naltrexone in nondependent recreational opioid users.
Topics: Adolescent; Adult; Cross-Over Studies; Delayed-Action Preparations; Discrimination, Psychological; Double-Blind Method; Drug Combinations; Drug Users; Female; Humans; Male; Middle Aged; Naltrexone; Oxycodone; Reinforcement, Psychology; Substance Abuse, Intravenous; Young Adult | 2016 |
Psychiatric symptoms, quality of life, and HIV status among people using opioids in Saint Petersburg, Russia.
Topics: Adult; Female; HIV Seropositivity; Humans; Male; Mental Disorders; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Psychiatric Status Rating Scales; Quality of Life; Russia; Substance Abuse, Intravenous; Young Adult | 2017 |
Drug use and HIV risk outcomes in opioid-injecting men in the Republic of Georgia: behavioral treatment + naltrexone compared to usual care.
Topics: Adult; Behavior Therapy; Combined Modality Therapy; Counseling; Directive Counseling; Female; Georgia (Republic); HIV Infections; Humans; Male; Naltrexone; Opioid-Related Disorders; Patient Education as Topic; Risk-Taking; Substance Abuse, Intravenous; Treatment Outcome | 2012 |
Depot naltrexone decreases rewarding properties of sugar in patients with opioid dependence.
Topics: Adult; Analysis of Variance; Cues; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Motivation; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Pilot Projects; Reward; Substance Abuse, Intravenous; Sucrose; Taste Perception | 2012 |
Behavioral treatment + naltrexone reduces drug use and legal problems in the Republic of Georgia.
Topics: Adult; Behavior Therapy; Georgia (Republic); Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Substance Abuse, Intravenous; Treatment Outcome | 2012 |
Risk-taking propensity as a predictor of induction onto naltrexone treatment for opioid dependence.
Topics: Administration, Oral; Adult; Baltimore; Cocaine-Related Disorders; Conditioning, Operant; Female; Heroin Dependence; Humans; Male; Medication Adherence; Middle Aged; Naltrexone; Narcotic Antagonists; Odds Ratio; Opioid-Related Disorders; Patient Acceptance of Health Care; Personality Assessment; Psychometrics; Rehabilitation, Vocational; Risk-Taking; Sheltered Workshops; Substance Abuse Detection; Substance Abuse, Intravenous | 2012 |
Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cocaine-Related Disorders; Employment; Female; Humans; Male; Medication Adherence; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Patient Dropouts; Reinforcement, Psychology; Substance Abuse, Intravenous; Substance-Related Disorders; Workplace | 2013 |
Controlled, randomized trial in maintenance treatment of intravenous buprenorphine dependence with naltrexone, methadone or buprenorphine: a novel study.
Topics: Administration, Oral; Administration, Sublingual; Adolescent; Adult; Age Distribution; Buprenorphine; Humans; Male; Methadone; Middle Aged; Naltrexone; Socioeconomic Factors; Substance Abuse, Intravenous; Treatment Outcome | 2003 |
Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia.
Topics: Adult; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Heroin; Heroin Dependence; HIV Infections; Humans; Male; Naltrexone; Narcotic Antagonists; Psychotherapy; Russia; Secondary Prevention; Substance Abuse, Intravenous; Substance Withdrawal Syndrome | 2006 |
Hepatitis C virus eradication in intravenous drug users maintained with subcutaneous naltrexone implants.
Topics: Adolescent; Adult; Antiviral Agents; Drug Implants; Female; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Patient Compliance; Prospective Studies; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome | 2007 |
Determination of naltrexone dosage for narcotic agonist blockade in detoxified Asian addicts.
Topics: Adult; Arousal; Cross-Cultural Comparison; Dose-Response Relationship, Drug; Double-Blind Method; Heroin; Heroin Dependence; Humans; Malaysia; Male; Naltrexone; Neurologic Examination; Receptors, Opioid; Substance Abuse, Intravenous | 1994 |
[Effect of methadone or naltrexone on the course of transaminases in parenteral drug users with hepatitis C virus infection].
Topics: Adult; Female; Hepatitis C; Humans; Liver; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Necrosis; Prospective Studies; Substance Abuse, Intravenous; Transaminases | 1997 |
Intravenous cocaine challenges during naltrexone maintenance: a preliminary study.
Topics: Adult; Blood Pressure; Cocaine; Double-Blind Method; Female; Heart Rate; Humans; Male; Naltrexone; Placebo Effect; Substance Abuse, Intravenous | 1992 |
16 other study(ies) available for naltrexone and Drug Abuse, Intravenous
Article | Year |
---|---|
Management of Opioid Misuse and Opioid Use Disorders Among Youth.
Topics: Adolescent; Adolescent Medicine; Behavior Therapy; Buprenorphine; Cause of Death; Combined Modality Therapy; Cross-Sectional Studies; Delayed-Action Preparations; Female; Humans; Male; Naltrexone; Opioid-Related Disorders; Pediatrics; Self-Help Groups; Substance Abuse, Intravenous; United States; Young Adult | 2020 |
Use of naltrexone in ketamine dependence.
Topics: Adult; Craving; Humans; Ketamine; Male; Naltrexone; Narcotic Antagonists; Substance Abuse, Intravenous; Substance Withdrawal Syndrome; Treatment Outcome | 2014 |
Factors associated with willingness to take extended release naltrexone among injection drug users.
Topics: Adult; Canada; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Patient Acceptance of Health Care; Socioeconomic Factors; Substance Abuse, Intravenous | 2015 |
Predictors of Continued Use of Extended-Released Naltrexone (XR-NTX) for Opioid-Dependence: An Analysis of Heroin and Non-Heroin Opioid Users in Los Angeles County.
Topics: Adult; Craving; Delayed-Action Preparations; Female; Heroin Dependence; Humans; Los Angeles; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Substance Abuse, Intravenous | 2016 |
The opioid receptor antagonist naltrexone attenuates reinstatement of amphetamine drug-seeking in the rat.
Topics: Amphetamine; Animals; Appetitive Behavior; Behavior, Addictive; Behavior, Animal; Conditioning, Operant; Dopamine Agents; Dose-Response Relationship, Drug; Extinction, Psychological; Feeding Behavior; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Reward; Self Administration; Substance Abuse, Intravenous | 2009 |
Intravenous self-administration of etonitazene alone and combined with cocaine in rhesus monkeys: comparison with heroin and antagonism by naltrexone and naloxonazine.
Topics: Animals; Benzimidazoles; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Drug Interactions; Female; Heroin; Injections, Intravenous; Macaca mulatta; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Receptors, Opioid, mu; Reinforcement, Psychology; Self Administration; Substance Abuse, Intravenous | 2009 |
Chronic ulcers caused by injection of substances: healing aided by naltrexone.
Topics: Chronic Disease; Diabetes Mellitus, Type 1; Drug Implants; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Obesity; Skin Ulcer; Substance Abuse, Intravenous; Wound Healing | 2009 |
Russian injected drug use soars in face of political inertia.
Topics: Drug Implants; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Politics; Russia; Substance Abuse, Intravenous | 2010 |
Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case-series and feasibility.
Topics: Adolescent; Adult; Buprenorphine; Delayed-Action Preparations; Drug Administration Schedule; Feasibility Studies; Female; Humans; Injections, Subcutaneous; Male; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Parents; Patient Satisfaction; Retrospective Studies; Secondary Prevention; Substance Abuse Detection; Substance Abuse, Intravenous; Treatment Outcome; Young Adult | 2010 |
Addiction treatment in Russia.
Topics: Behavior, Addictive; Buprenorphine; Delayed-Action Preparations; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Recurrence; Russia; Substance Abuse, Intravenous; Suicide Prevention | 2010 |
Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users.
Topics: Adult; Buprenorphine; Emergency Medical Services; Female; Humans; Inactivation, Metabolic; Male; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Severity of Illness Index; Substance Abuse, Intravenous; Substance Withdrawal Syndrome | 2003 |
Reinstatement of cocaine-seeking behavior in rats is attenuated following repeated treatment with the opioid receptor antagonist naltrexone.
Topics: Animals; Behavior, Animal; Cocaine-Related Disorders; Dose-Response Relationship, Drug; Extinction, Psychological; Male; Naltrexone; Narcotic Antagonists; Rats; Receptors, Opioid, mu; Recurrence; Substance Abuse, Intravenous | 2005 |
Enhancing hepatitis C treatment uptake and outcomes for injection drug users.
Topics: Antiviral Agents; Hepatitis C; Humans; Interferons; Naltrexone; Narcotic Antagonists; Patient Compliance; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome | 2007 |
Behavioral economic analysis of drug preference using multiple choice procedure data.
Topics: Choice Behavior; Economics; Fentanyl; Fluoxetine; Hallucinogens; Humans; Hydromorphone; Injections, Intramuscular; Methadone; Models, Psychological; Motivation; N-Methyl-3,4-methylenedioxyamphetamine; Naltrexone; Narcotics; Psychotropic Drugs; Recreation; Selective Serotonin Reuptake Inhibitors; Substance Abuse, Intravenous; Substance-Related Disorders | 2008 |
Heroin addiction and naltrexone.
Topics: Australia; Heroin; Humans; Naltrexone; Narcotic Antagonists; Patient Education as Topic; Substance Abuse, Intravenous; Treatment Outcome | 1998 |
NIDA's Medication Development Program--1989.
Topics: Acquired Immunodeficiency Syndrome; Brain; Cocaine; Drug and Narcotic Control; Female; Heroin Dependence; Humans; Infant, Newborn; Methadone; Methadyl Acetate; Naltrexone; Pregnancy; Psychotropic Drugs; Research Support as Topic; Risk Factors; Substance Abuse, Intravenous; Substance-Related Disorders | 1989 |